ImmunityBio (IBRX) Goodwill & Intangibles (2014 - 2026)

ImmunityBio (IBRX) has 12 years of Goodwill & Intangibles data on file, last reported at $12.9 million in Q1 2026.

• On a quarterly basis, Goodwill & Intangibles fell 16.56% year-over-year to $12.9 million in Q1 2026; TTM through Mar 2026 was $12.9 million, a 16.56% decrease from a year earlier, with the FY2025 full-year figure at $14.0 million, down 12.43% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $12.9 million, down from $14.0 million in the prior quarter.
• Over the last five years, Goodwill & Intangibles for IBRX reached as high as $22.3 million in Q1 2022 and fell as low as $12.9 million in Q1 2026.
• Historically, Goodwill & Intangibles has averaged $17.4 million across 5 years, with a median of $16.6 million in 2024.
• Across the five-year window, Goodwill & Intangibles surged 1454.17% in 2022 and fell 16.56% in 2026, its largest moves.
• Year by year, Goodwill & Intangibles stood at $20.0 million in 2022, then retreated by 14.55% to $17.1 million in 2023, then dropped by 6.79% to $15.9 million in 2024, then dropped by 12.43% to $14.0 million in 2025, then fell by 7.65% to $12.9 million in 2026.
• Per Business Quant data, the three most recent Goodwill & Intangibles figures were $12.9 million in Q1 2026, $14.0 million in Q4 2025, and $14.5 million in Q3 2025.